The invisible lightness of healing

Phototherapy deemed low risk for atopic eczema patients who find the treatments simple and effective.

Benefits of exposing skin to ultraviolet light for people with atopic eczema far outweighs the risk, according to a study that will leave clinicians to rest easy, knowing that prescribed phototherapy does more good than harm.

Launching the VCHRI Strategic Plan 2022-2027: Integrating Research Innovation and Health Care

The Vancouver Coastal Health Research Institute (VCHRI) has launched the VCHRI Strategic Plan 2022-2027: Integrating Research Innovation and Health Care. Read the strategic plan on their website to learn more about their plan to achieve meaningful and sustainable outcomes for patients, families and the research community:

Ask an expert: How can I stay safe in the sun?

Our expert shares science-based and myth-busting insights on how UV rays can affect your skin, regardless of your skin tone.

While soaking up the rays on a beach or hike can give us a boost of vitamin D and have a positive effect on our mood, too much can lead to premature skin ageing and increase the risk of developing skin cancer. Vancouver Coastal Health Research Institute (VCHRI) researcher Dr. Sunil Kalia details why we should all be sun-smart.

Heath care priority management post-COVID-19

The pandemic has shone a light on the need for decision-making tools and public input to support health-care resource allocation.

Deciding which patients to treat and when were among the many challenges presented by the COVID-19 pandemic. 

With limited resources and staff available to care for patients, health care decision-makers were faced with an unprecedented situation in which patients and health-care resources needed to be allocated based on ever-evolving rules and guidelines. 

Linking hospitals to province-wide pharmacies to prevent medication harm

Software that shares patient information between hospital and community care providers has the ability to protect patients from adverse drug reactions.

Harm caused by the use or misuse of prescription medications leads to around two million visits to emergency departments, 700,000 hospital admissions and $1 billion in health care expenditures in Canada each year. Known as adverse drug events (ADEs), they rank between the fourth and sixth leading causes of death in Canada. 

The Centre has lost a good friend with the death of J. Mark FitzGerald

Dr. J. Mark FitzGerald was the Director of the Centre for Clinical Epidemiology & Evaluation (C2E2) from 2001 to 2010.  He was instrumental in the early development of the Centre and the research careers of its members.

"As a youngish and under-confident clinician researcher who suffered from 'imposter syndrome', Mark was consistently supportive, friendly, and inclusive.  He grew C2E2 into a place where everyone felt welcome", recalls Dr. Margaret McGregor (Clinical Associate Professor, UBC Department of Family Practice).

Diagnostic Yield of Screening for SARS-CoV-2 among Patients Admitted for Alternate Diagnoses

Phil Davis, Rhonda J. Rosychuk, Jeffrey P Hau, Ivy Cheng, Andrew D. McRae, Raoul Daoust, Eddy Lang, Joel Turner, Jaspreet Khangura, Patrick T. Fok, Maja Stachura, Baljeet Brar, Corinne Hohl


Objectives To determine the diagnostic yield of screening patients for SARS-CoV-2 who were admitted with a diagnosis unrelated to COVID-19, and identify risk factors for positive tests.

Design Cohort from the Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) registry

An Integrated Framework to Conceptualize and Develop the Vancouver Airways Health Literacy Tool (VAHLT)

Iraj Poureslami, Jacek Kopec, Noah Tregobov, Jessica Shum, Rick Sawatzky, Richard Hohn, and J. Mark FitzGerald


Partnering on research for better COPD care

Before his diagnosis, Dan Smith was an active walker and snowbird, often traveling with his wife overseas. Then, 10 years ago, he started having trouble breathing. “I ended up in the hospital, which is when I was told that I have severe COPD,” recalls the 77-year-old.